<!-- Non-Uterine LMS: Hero Section -->
<link rel="stylesheet" href="./styles.css" />
<section class="nlmsf-hero">
  <div class="nlmsf-hero-badge">
    <span class="nlmsf-hero-icon">ðŸ§¬</span>
    <span class="nlmsf-hero-badge-text">Research â€¢ Treatment â€¢ Support</span>
  </div>
  <h1 class="nlmsf-hero-title">
    Nonâ€‘Uterine Leiomyosarcoma
  </h1>
  <p class="nlmsf-hero-subtitle">
    Curated, nationally-relevant updates on maintenance therapy after first-line treatment and ongoing combination immunotherapy/chemotherapy studies in advanced soft tissue sarcoma, with emphasis on leiomyosarcoma.
  </p>
  <div class="nlmsf-hero-divider"></div>
  <div class="nlmsf-hero-tags">
    <span class="tag tag-purple">Soft Tissue Sarcoma</span>
    <span class="tag tag-blue">Maintenance Therapy</span>
    <span class="tag tag-teal">Clinical Trials</span>
  </div>
</section>
